GlassScriptPhysician profile
Inessa M Gelfand
NPI 1528080637
$8,713.16
in general payments reported to CMS, 2019-2025
50 companies · $2,725 in 2025
The $2,725 reported for 2025 was more than what 82% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,641 · 2020: $528 · 2021: $206 · 2022: $225 · 2023: $928 · 2024: $2,460 · 2025: $2,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,978 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,977.54 |
| Education | $134.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,030.98 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $686.29 | 2019-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $686.08 | 2019-2025 | Evenity, Repatha, Repatha |
| Lilly USA, LLC | $658.23 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Abbott Laboratories | $480.40 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $393.34 | 2019-2025 | |
| Abbvie INC. | $389.93 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $379.58 | 2019-2025 | Jardiance, Tradjenta |
| Amarin Pharma, INC. | $364.55 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $335.15 | 2019 | |
| Astellas Pharma US INC | $301.18 | 2023-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $263.69 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $187.02 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Ibsa Pharma INC. | $182.96 | 2020-2025 | Tirosint, Licart, Flector |
| Corcept Therapeutics | $181.34 | 2019-2025 | Korlym |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $169.77 | 2025 | Minimed 780g, Abre |
| Astrazeneca Pharmaceuticals LP | $168.50 | 2019-2024 | Farxiga |
| Beta Bionics, INC. | $155.78 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.12 | 2019-2022 | |
| Insulet Corporation | $128.17 | 2025 | Omnipod |
| Scilex Pharmaceuticals INC. | $125.60 | 2019-2020 | |
| Radius Health, INC. | $125.02 | 2025 | Tymlos |
| Vivus LLC | $124.21 | 2020-2025 | Qsymia, Pancreaze |
| Ascendis Pharma Endocrinology INC | $104.09 | 2024-2025 | Yorvipath |
| Merck Sharp & Dohme LLC | $84.29 | 2019 | |
| Madrigal Pharmaceuticals | $67.06 | 2025 | Rezdiffra |
| Exact Sciences Corporation | $66.36 | 2023-2024 | Cologuard Collection Kit |
| Tandem Diabetes Care, INC. | $63.45 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Ardelyx, INC. | $60.56 | 2024 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $50.42 | 2025 | |
| Mannkind Corporation | $50.12 | 2019 | |
| Alexion Pharmaceuticals, INC. | $49.60 | 2024-2025 | Strensiq |
| Ultragenyx Pharmaceutical INC. | $42.55 | 2020-2024 | Crysvita |
| Amneal Pharmaceuticals LLC | $38.17 | 2025 | Unithroid |
| Sumitomo Pharma America, INC. | $33.11 | 2024 | Gemtesa |
| Neurocrine Biosciences, INC. | $32.66 | 2025 | |
| Acella Pharmaceuticals, LLC | $32.64 | 2025 | NP Thyroid 60 |
| Takeda Pharmaceuticals U.S.A., INC. | $32.60 | 2019 | |
| Glaxosmithkline, LLC. | $31.67 | 2020-2022 | |
| Averitas Pharma INC. | $29.21 | 2025 | Qutenza |
| Amphastar Pharmaceuticals, INC. | $22.43 | 2025 | |
| Antares Pharma, INC. | $21.26 | 2025 | Xyosted |
| Sunovion Pharmaceuticals INC. | $19.66 | 2019 | |
| Phathom Pharmaceuticals, INC. | $19.39 | 2024 | Voquezna |
| Pfizer INC. | $18.26 | 2019 | |
| Clarus Therapeutics INC. | $17.93 | 2021 | |
| Bioventus LLC | $16.09 | 2019 | |
| Idorsia Pharmaceuticals US INC | $14.91 | 2024 | Quviviq |
| Ipsen Biopharmaceuticals, INC | $14.79 | 2019 | |
| Fidia Pharma USA INC. | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inessa Gelfand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.